pharmaceutical investing Scilex Announces Pricing and Availability of ZTlido for the Commercial Launch of its First Product in October of 2018
pharmaceutical investing Sorrento Therapeutics Subsidiary, Scilex, Raises $140 million in Non-Dilutive Royalty-Based Financing
E-Power Resources Inc. Announces Closing of Oversubscribed Hard Dollar and Flow-through Private Placements
